BMC Medical Genomics-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1205377, encodeId=2e5112053e7da, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：生物信息分析 经验分享：从提交到接收四个月，中间修了两次，算是比较幸运的，遇到了好编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fc1b5547492, createdName=ms6000000247118819, createdTime=Wed Mar 23 21:55:57 CST 2022, time=2022-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2142457, encodeId=938f214245e63, content=还接受纯生信吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9048588526, createdName=ms9000001377282776, createdTime=Mon Jun 12 22:33:13 CST 2023, time=2023-06-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=966158, encodeId=e71b9661585a, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：心血管 经验分享：2020-12-25投稿，在编辑手里呆了几天后under review，2021-2月底邮件询问审稿状态（编辑很快就回复了还在审稿，这点还是比较给力的），2021-3-10状态变为Reviews Received，2021-3-22给出大修、意见给的也很专业、对文章提高有帮助（杂志社要求2021-6-20之前返回修改稿，时间给的比较充分），努力干了一个月，2021-4-30重新提交，technical check 4天后under review，2021-5-17状态变为了Reviews Received，目前本人祈祷不要拒稿中ing......个人觉得这本杂志还是比较靠谱的，个人经验，仅供参考，无意引战，谢绝反驳，也祝愿各位看官的paper投哪中哪，当然也包括我自己！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2acd90203, createdName=aipeter9194, createdTime=Mon May 17 07:31:28 CST 2021, time=2021-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2194070, encodeId=622221940e074, content=23年12月初peer review，现在显示The editors' decision can take several weeks as they may consult peer reviewers.有没有小伙伴知道是什么意思啊？我中途一直在关注网站明明显示的都是邀请审稿人，也没看有审稿人同意审稿。是系统不会显示吗？有没有必要写邮件催一下。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211209/8c790d426a7f41acb532cdb3a72c5ac7/68f2ff877eb74ef395af90eaacbc8c98.jpg, createdBy=04ed1994321, createdName=Dr.sugar, createdTime=Tue Mar 19 14:15:05 CST 2024, time=2024-03-19, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2211132, encodeId=109a2211132fb, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：特别无语，投稿9个月，中间小修，又等了5个月，最后一句话拒稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9b08717541, createdName=ms2000000985925584, createdTime=Sat Jun 22 12:40:50 CST 2024, time=2024-06-22, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2193258, encodeId=7038219325860, content=审稿速度:24.0 | 投稿命中率:25.0 经验分享：23-11-22投的，现在还在邀请编辑，写了几次催稿信，但都只是说还在邀请。着急的慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a838857884, createdName=ms5000000372122066, createdTime=Thu Mar 14 19:13:11 CST 2024, time=2024-03-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2186822, encodeId=01352186822ba, content=审稿速度:2.0 偏重的研究方向：非肿瘤 经验分享：2个月review，给了2周小修之后返回，审稿人不专业，发的孟德尔随机化完全不懂乱审一通，2个月返回之后拒掉了，全程4个月，有类似研究的慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b6f8797712, createdName=ms3000001167906308, createdTime=Sat Feb 10 18:23:39 CST 2024, time=2024-02-10, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2119112, encodeId=91a3211911291, content=朋友们，技术审查需要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f488130699, createdName=ms9000000792208563, createdTime=Sun Mar 12 19:41:24 CST 2023, time=2023-03-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2183750, encodeId=bb0a2183e5072, content=审稿速度:6.0 经验分享：马上4个月了，无语, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9b08717541, createdName=ms2000000985925584, createdTime=Wed Jan 24 20:44:15 CST 2024, time=2024-01-24, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2176028, encodeId=c65f21e60284f, content=偏重的研究方向：肿瘤分子流行病学 经验分享：2个月了，还是Editors invited ,还有希望不，有没有发过大佬的给分享一下投稿经验？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61ce6163316, createdName=ms8000001907184267, createdTime=Wed Dec 20 07:41:23 CST 2023, time=2023-12-20, status=1, ipAttribution=山东省)]

2022-03-23 ms6000000247118819

审稿速度:6.0 | 投稿命中率:75.0
偏重的研究方向：生物信息分析
经验分享：从提交到接收四个月，中间修了两次，算是比较幸运的，遇到了好编辑

94 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=1205377, encodeId=2e5112053e7da, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：生物信息分析 经验分享：从提交到接收四个月，中间修了两次，算是比较幸运的，遇到了好编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fc1b5547492, createdName=ms6000000247118819, createdTime=Wed Mar 23 21:55:57 CST 2022, time=2022-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2142457, encodeId=938f214245e63, content=还接受纯生信吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9048588526, createdName=ms9000001377282776, createdTime=Mon Jun 12 22:33:13 CST 2023, time=2023-06-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=966158, encodeId=e71b9661585a, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：心血管 经验分享：2020-12-25投稿，在编辑手里呆了几天后under review，2021-2月底邮件询问审稿状态（编辑很快就回复了还在审稿，这点还是比较给力的），2021-3-10状态变为Reviews Received，2021-3-22给出大修、意见给的也很专业、对文章提高有帮助（杂志社要求2021-6-20之前返回修改稿，时间给的比较充分），努力干了一个月，2021-4-30重新提交，technical check 4天后under review，2021-5-17状态变为了Reviews Received，目前本人祈祷不要拒稿中ing......个人觉得这本杂志还是比较靠谱的，个人经验，仅供参考，无意引战，谢绝反驳，也祝愿各位看官的paper投哪中哪，当然也包括我自己！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2acd90203, createdName=aipeter9194, createdTime=Mon May 17 07:31:28 CST 2021, time=2021-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2194070, encodeId=622221940e074, content=23年12月初peer review，现在显示The editors' decision can take several weeks as they may consult peer reviewers.有没有小伙伴知道是什么意思啊？我中途一直在关注网站明明显示的都是邀请审稿人，也没看有审稿人同意审稿。是系统不会显示吗？有没有必要写邮件催一下。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211209/8c790d426a7f41acb532cdb3a72c5ac7/68f2ff877eb74ef395af90eaacbc8c98.jpg, createdBy=04ed1994321, createdName=Dr.sugar, createdTime=Tue Mar 19 14:15:05 CST 2024, time=2024-03-19, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2211132, encodeId=109a2211132fb, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：特别无语，投稿9个月，中间小修，又等了5个月，最后一句话拒稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9b08717541, createdName=ms2000000985925584, createdTime=Sat Jun 22 12:40:50 CST 2024, time=2024-06-22, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2193258, encodeId=7038219325860, content=审稿速度:24.0 | 投稿命中率:25.0 经验分享：23-11-22投的，现在还在邀请编辑，写了几次催稿信，但都只是说还在邀请。着急的慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a838857884, createdName=ms5000000372122066, createdTime=Thu Mar 14 19:13:11 CST 2024, time=2024-03-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2186822, encodeId=01352186822ba, content=审稿速度:2.0 偏重的研究方向：非肿瘤 经验分享：2个月review，给了2周小修之后返回，审稿人不专业，发的孟德尔随机化完全不懂乱审一通，2个月返回之后拒掉了，全程4个月，有类似研究的慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b6f8797712, createdName=ms3000001167906308, createdTime=Sat Feb 10 18:23:39 CST 2024, time=2024-02-10, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2119112, encodeId=91a3211911291, content=朋友们，技术审查需要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f488130699, createdName=ms9000000792208563, createdTime=Sun Mar 12 19:41:24 CST 2023, time=2023-03-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2183750, encodeId=bb0a2183e5072, content=审稿速度:6.0 经验分享：马上4个月了，无语, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9b08717541, createdName=ms2000000985925584, createdTime=Wed Jan 24 20:44:15 CST 2024, time=2024-01-24, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2176028, encodeId=c65f21e60284f, content=偏重的研究方向：肿瘤分子流行病学 经验分享：2个月了，还是Editors invited ,还有希望不，有没有发过大佬的给分享一下投稿经验？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61ce6163316, createdName=ms8000001907184267, createdTime=Wed Dec 20 07:41:23 CST 2023, time=2023-12-20, status=1, ipAttribution=山东省)]

2023-06-12 ms9000001377282776 来自广东省

还接受纯生信吗

125 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=1205377, encodeId=2e5112053e7da, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：生物信息分析 经验分享：从提交到接收四个月，中间修了两次，算是比较幸运的，遇到了好编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fc1b5547492, createdName=ms6000000247118819, createdTime=Wed Mar 23 21:55:57 CST 2022, time=2022-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2142457, encodeId=938f214245e63, content=还接受纯生信吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9048588526, createdName=ms9000001377282776, createdTime=Mon Jun 12 22:33:13 CST 2023, time=2023-06-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=966158, encodeId=e71b9661585a, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：心血管 经验分享：2020-12-25投稿，在编辑手里呆了几天后under review，2021-2月底邮件询问审稿状态（编辑很快就回复了还在审稿，这点还是比较给力的），2021-3-10状态变为Reviews Received，2021-3-22给出大修、意见给的也很专业、对文章提高有帮助（杂志社要求2021-6-20之前返回修改稿，时间给的比较充分），努力干了一个月，2021-4-30重新提交，technical check 4天后under review，2021-5-17状态变为了Reviews Received，目前本人祈祷不要拒稿中ing......个人觉得这本杂志还是比较靠谱的，个人经验，仅供参考，无意引战，谢绝反驳，也祝愿各位看官的paper投哪中哪，当然也包括我自己！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2acd90203, createdName=aipeter9194, createdTime=Mon May 17 07:31:28 CST 2021, time=2021-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2194070, encodeId=622221940e074, content=23年12月初peer review，现在显示The editors' decision can take several weeks as they may consult peer reviewers.有没有小伙伴知道是什么意思啊？我中途一直在关注网站明明显示的都是邀请审稿人，也没看有审稿人同意审稿。是系统不会显示吗？有没有必要写邮件催一下。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211209/8c790d426a7f41acb532cdb3a72c5ac7/68f2ff877eb74ef395af90eaacbc8c98.jpg, createdBy=04ed1994321, createdName=Dr.sugar, createdTime=Tue Mar 19 14:15:05 CST 2024, time=2024-03-19, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2211132, encodeId=109a2211132fb, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：特别无语，投稿9个月，中间小修，又等了5个月，最后一句话拒稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9b08717541, createdName=ms2000000985925584, createdTime=Sat Jun 22 12:40:50 CST 2024, time=2024-06-22, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2193258, encodeId=7038219325860, content=审稿速度:24.0 | 投稿命中率:25.0 经验分享：23-11-22投的，现在还在邀请编辑，写了几次催稿信，但都只是说还在邀请。着急的慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a838857884, createdName=ms5000000372122066, createdTime=Thu Mar 14 19:13:11 CST 2024, time=2024-03-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2186822, encodeId=01352186822ba, content=审稿速度:2.0 偏重的研究方向：非肿瘤 经验分享：2个月review，给了2周小修之后返回，审稿人不专业，发的孟德尔随机化完全不懂乱审一通，2个月返回之后拒掉了，全程4个月，有类似研究的慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b6f8797712, createdName=ms3000001167906308, createdTime=Sat Feb 10 18:23:39 CST 2024, time=2024-02-10, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2119112, encodeId=91a3211911291, content=朋友们，技术审查需要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f488130699, createdName=ms9000000792208563, createdTime=Sun Mar 12 19:41:24 CST 2023, time=2023-03-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2183750, encodeId=bb0a2183e5072, content=审稿速度:6.0 经验分享：马上4个月了，无语, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9b08717541, createdName=ms2000000985925584, createdTime=Wed Jan 24 20:44:15 CST 2024, time=2024-01-24, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2176028, encodeId=c65f21e60284f, content=偏重的研究方向：肿瘤分子流行病学 经验分享：2个月了，还是Editors invited ,还有希望不，有没有发过大佬的给分享一下投稿经验？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61ce6163316, createdName=ms8000001907184267, createdTime=Wed Dec 20 07:41:23 CST 2023, time=2023-12-20, status=1, ipAttribution=山东省)]

2021-05-17 aipeter9194

审稿速度:6.0 | 投稿命中率:50.0
偏重的研究方向：心血管
经验分享：2020-12-25投稿，在编辑手里呆了几天后under review，2021-2月底邮件询问审稿状态（编辑很快就回复了还在审稿，这点还是比较给力的），2021-3-10状态变为Reviews Received，2021-3-22给出大修、意见给的也很专业、对文章提高有帮助（杂志社要求2021-6-20之前返回修改稿，时间给的比较充分），努力干了一个月，2021-4-30重新提交，technical check 4天后under review，2021-5-17状态变为了Reviews Received，目前本人祈祷不要拒稿中ing......个人觉得这本杂志还是比较靠谱的，个人经验，仅供参考，无意引战，谢绝反驳，也祝愿各位看官的paper投哪中哪，当然也包括我自己！！！

132 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=1205377, encodeId=2e5112053e7da, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：生物信息分析 经验分享：从提交到接收四个月，中间修了两次，算是比较幸运的，遇到了好编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fc1b5547492, createdName=ms6000000247118819, createdTime=Wed Mar 23 21:55:57 CST 2022, time=2022-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2142457, encodeId=938f214245e63, content=还接受纯生信吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9048588526, createdName=ms9000001377282776, createdTime=Mon Jun 12 22:33:13 CST 2023, time=2023-06-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=966158, encodeId=e71b9661585a, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：心血管 经验分享：2020-12-25投稿，在编辑手里呆了几天后under review，2021-2月底邮件询问审稿状态（编辑很快就回复了还在审稿，这点还是比较给力的），2021-3-10状态变为Reviews Received，2021-3-22给出大修、意见给的也很专业、对文章提高有帮助（杂志社要求2021-6-20之前返回修改稿，时间给的比较充分），努力干了一个月，2021-4-30重新提交，technical check 4天后under review，2021-5-17状态变为了Reviews Received，目前本人祈祷不要拒稿中ing......个人觉得这本杂志还是比较靠谱的，个人经验，仅供参考，无意引战，谢绝反驳，也祝愿各位看官的paper投哪中哪，当然也包括我自己！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2acd90203, createdName=aipeter9194, createdTime=Mon May 17 07:31:28 CST 2021, time=2021-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2194070, encodeId=622221940e074, content=23年12月初peer review，现在显示The editors' decision can take several weeks as they may consult peer reviewers.有没有小伙伴知道是什么意思啊？我中途一直在关注网站明明显示的都是邀请审稿人，也没看有审稿人同意审稿。是系统不会显示吗？有没有必要写邮件催一下。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211209/8c790d426a7f41acb532cdb3a72c5ac7/68f2ff877eb74ef395af90eaacbc8c98.jpg, createdBy=04ed1994321, createdName=Dr.sugar, createdTime=Tue Mar 19 14:15:05 CST 2024, time=2024-03-19, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2211132, encodeId=109a2211132fb, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：特别无语，投稿9个月，中间小修，又等了5个月，最后一句话拒稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9b08717541, createdName=ms2000000985925584, createdTime=Sat Jun 22 12:40:50 CST 2024, time=2024-06-22, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2193258, encodeId=7038219325860, content=审稿速度:24.0 | 投稿命中率:25.0 经验分享：23-11-22投的，现在还在邀请编辑，写了几次催稿信，但都只是说还在邀请。着急的慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a838857884, createdName=ms5000000372122066, createdTime=Thu Mar 14 19:13:11 CST 2024, time=2024-03-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2186822, encodeId=01352186822ba, content=审稿速度:2.0 偏重的研究方向：非肿瘤 经验分享：2个月review，给了2周小修之后返回，审稿人不专业，发的孟德尔随机化完全不懂乱审一通，2个月返回之后拒掉了，全程4个月，有类似研究的慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b6f8797712, createdName=ms3000001167906308, createdTime=Sat Feb 10 18:23:39 CST 2024, time=2024-02-10, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2119112, encodeId=91a3211911291, content=朋友们，技术审查需要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f488130699, createdName=ms9000000792208563, createdTime=Sun Mar 12 19:41:24 CST 2023, time=2023-03-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2183750, encodeId=bb0a2183e5072, content=审稿速度:6.0 经验分享：马上4个月了，无语, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9b08717541, createdName=ms2000000985925584, createdTime=Wed Jan 24 20:44:15 CST 2024, time=2024-01-24, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2176028, encodeId=c65f21e60284f, content=偏重的研究方向：肿瘤分子流行病学 经验分享：2个月了，还是Editors invited ,还有希望不，有没有发过大佬的给分享一下投稿经验？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61ce6163316, createdName=ms8000001907184267, createdTime=Wed Dec 20 07:41:23 CST 2023, time=2023-12-20, status=1, ipAttribution=山东省)]

2024-03-19 Dr.sugar 来自江苏省

23年12月初peer review，现在显示The editors' decision can take several weeks as they may consult peer reviewers.有没有小伙伴知道是什么意思啊？我中途一直在关注网站明明显示的都是邀请审稿人，也没看有审稿人同意审稿。是系统不会显示吗？有没有必要写邮件催一下。

134 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1205377, encodeId=2e5112053e7da, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：生物信息分析 经验分享：从提交到接收四个月，中间修了两次，算是比较幸运的，遇到了好编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fc1b5547492, createdName=ms6000000247118819, createdTime=Wed Mar 23 21:55:57 CST 2022, time=2022-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2142457, encodeId=938f214245e63, content=还接受纯生信吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9048588526, createdName=ms9000001377282776, createdTime=Mon Jun 12 22:33:13 CST 2023, time=2023-06-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=966158, encodeId=e71b9661585a, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：心血管 经验分享：2020-12-25投稿，在编辑手里呆了几天后under review，2021-2月底邮件询问审稿状态（编辑很快就回复了还在审稿，这点还是比较给力的），2021-3-10状态变为Reviews Received，2021-3-22给出大修、意见给的也很专业、对文章提高有帮助（杂志社要求2021-6-20之前返回修改稿，时间给的比较充分），努力干了一个月，2021-4-30重新提交，technical check 4天后under review，2021-5-17状态变为了Reviews Received，目前本人祈祷不要拒稿中ing......个人觉得这本杂志还是比较靠谱的，个人经验，仅供参考，无意引战，谢绝反驳，也祝愿各位看官的paper投哪中哪，当然也包括我自己！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2acd90203, createdName=aipeter9194, createdTime=Mon May 17 07:31:28 CST 2021, time=2021-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2194070, encodeId=622221940e074, content=23年12月初peer review，现在显示The editors' decision can take several weeks as they may consult peer reviewers.有没有小伙伴知道是什么意思啊？我中途一直在关注网站明明显示的都是邀请审稿人，也没看有审稿人同意审稿。是系统不会显示吗？有没有必要写邮件催一下。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211209/8c790d426a7f41acb532cdb3a72c5ac7/68f2ff877eb74ef395af90eaacbc8c98.jpg, createdBy=04ed1994321, createdName=Dr.sugar, createdTime=Tue Mar 19 14:15:05 CST 2024, time=2024-03-19, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2211132, encodeId=109a2211132fb, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：特别无语，投稿9个月，中间小修，又等了5个月，最后一句话拒稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9b08717541, createdName=ms2000000985925584, createdTime=Sat Jun 22 12:40:50 CST 2024, time=2024-06-22, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2193258, encodeId=7038219325860, content=审稿速度:24.0 | 投稿命中率:25.0 经验分享：23-11-22投的，现在还在邀请编辑，写了几次催稿信，但都只是说还在邀请。着急的慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a838857884, createdName=ms5000000372122066, createdTime=Thu Mar 14 19:13:11 CST 2024, time=2024-03-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2186822, encodeId=01352186822ba, content=审稿速度:2.0 偏重的研究方向：非肿瘤 经验分享：2个月review，给了2周小修之后返回，审稿人不专业，发的孟德尔随机化完全不懂乱审一通，2个月返回之后拒掉了，全程4个月，有类似研究的慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b6f8797712, createdName=ms3000001167906308, createdTime=Sat Feb 10 18:23:39 CST 2024, time=2024-02-10, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2119112, encodeId=91a3211911291, content=朋友们，技术审查需要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f488130699, createdName=ms9000000792208563, createdTime=Sun Mar 12 19:41:24 CST 2023, time=2023-03-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2183750, encodeId=bb0a2183e5072, content=审稿速度:6.0 经验分享：马上4个月了，无语, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9b08717541, createdName=ms2000000985925584, createdTime=Wed Jan 24 20:44:15 CST 2024, time=2024-01-24, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2176028, encodeId=c65f21e60284f, content=偏重的研究方向：肿瘤分子流行病学 经验分享：2个月了，还是Editors invited ,还有希望不，有没有发过大佬的给分享一下投稿经验？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61ce6163316, createdName=ms8000001907184267, createdTime=Wed Dec 20 07:41:23 CST 2023, time=2023-12-20, status=1, ipAttribution=山东省)]

2024-06-22 ms2000000985925584 来自新疆

审稿速度:12.0 | 投稿命中率:5.0
经验分享：特别无语，投稿9个月，中间小修，又等了5个月，最后一句话拒稿了

60 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1205377, encodeId=2e5112053e7da, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：生物信息分析 经验分享：从提交到接收四个月，中间修了两次，算是比较幸运的，遇到了好编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fc1b5547492, createdName=ms6000000247118819, createdTime=Wed Mar 23 21:55:57 CST 2022, time=2022-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2142457, encodeId=938f214245e63, content=还接受纯生信吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9048588526, createdName=ms9000001377282776, createdTime=Mon Jun 12 22:33:13 CST 2023, time=2023-06-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=966158, encodeId=e71b9661585a, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：心血管 经验分享：2020-12-25投稿，在编辑手里呆了几天后under review，2021-2月底邮件询问审稿状态（编辑很快就回复了还在审稿，这点还是比较给力的），2021-3-10状态变为Reviews Received，2021-3-22给出大修、意见给的也很专业、对文章提高有帮助（杂志社要求2021-6-20之前返回修改稿，时间给的比较充分），努力干了一个月，2021-4-30重新提交，technical check 4天后under review，2021-5-17状态变为了Reviews Received，目前本人祈祷不要拒稿中ing......个人觉得这本杂志还是比较靠谱的，个人经验，仅供参考，无意引战，谢绝反驳，也祝愿各位看官的paper投哪中哪，当然也包括我自己！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2acd90203, createdName=aipeter9194, createdTime=Mon May 17 07:31:28 CST 2021, time=2021-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2194070, encodeId=622221940e074, content=23年12月初peer review，现在显示The editors' decision can take several weeks as they may consult peer reviewers.有没有小伙伴知道是什么意思啊？我中途一直在关注网站明明显示的都是邀请审稿人，也没看有审稿人同意审稿。是系统不会显示吗？有没有必要写邮件催一下。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211209/8c790d426a7f41acb532cdb3a72c5ac7/68f2ff877eb74ef395af90eaacbc8c98.jpg, createdBy=04ed1994321, createdName=Dr.sugar, createdTime=Tue Mar 19 14:15:05 CST 2024, time=2024-03-19, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2211132, encodeId=109a2211132fb, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：特别无语，投稿9个月，中间小修，又等了5个月，最后一句话拒稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9b08717541, createdName=ms2000000985925584, createdTime=Sat Jun 22 12:40:50 CST 2024, time=2024-06-22, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2193258, encodeId=7038219325860, content=审稿速度:24.0 | 投稿命中率:25.0 经验分享：23-11-22投的，现在还在邀请编辑，写了几次催稿信，但都只是说还在邀请。着急的慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a838857884, createdName=ms5000000372122066, createdTime=Thu Mar 14 19:13:11 CST 2024, time=2024-03-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2186822, encodeId=01352186822ba, content=审稿速度:2.0 偏重的研究方向：非肿瘤 经验分享：2个月review，给了2周小修之后返回，审稿人不专业，发的孟德尔随机化完全不懂乱审一通，2个月返回之后拒掉了，全程4个月，有类似研究的慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b6f8797712, createdName=ms3000001167906308, createdTime=Sat Feb 10 18:23:39 CST 2024, time=2024-02-10, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2119112, encodeId=91a3211911291, content=朋友们，技术审查需要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f488130699, createdName=ms9000000792208563, createdTime=Sun Mar 12 19:41:24 CST 2023, time=2023-03-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2183750, encodeId=bb0a2183e5072, content=审稿速度:6.0 经验分享：马上4个月了，无语, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9b08717541, createdName=ms2000000985925584, createdTime=Wed Jan 24 20:44:15 CST 2024, time=2024-01-24, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2176028, encodeId=c65f21e60284f, content=偏重的研究方向：肿瘤分子流行病学 经验分享：2个月了，还是Editors invited ,还有希望不，有没有发过大佬的给分享一下投稿经验？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61ce6163316, createdName=ms8000001907184267, createdTime=Wed Dec 20 07:41:23 CST 2023, time=2023-12-20, status=1, ipAttribution=山东省)]

2024-03-14 ms5000000372122066 来自广东省

审稿速度:24.0 | 投稿命中率:25.0
经验分享：23-11-22投的，现在还在邀请编辑，写了几次催稿信，但都只是说还在邀请。着急的慎投

0 0

[GetPortalCommentsPageByObjectIdResponse(id=1205377, encodeId=2e5112053e7da, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：生物信息分析 经验分享：从提交到接收四个月，中间修了两次，算是比较幸运的，遇到了好编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fc1b5547492, createdName=ms6000000247118819, createdTime=Wed Mar 23 21:55:57 CST 2022, time=2022-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2142457, encodeId=938f214245e63, content=还接受纯生信吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9048588526, createdName=ms9000001377282776, createdTime=Mon Jun 12 22:33:13 CST 2023, time=2023-06-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=966158, encodeId=e71b9661585a, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：心血管 经验分享：2020-12-25投稿，在编辑手里呆了几天后under review，2021-2月底邮件询问审稿状态（编辑很快就回复了还在审稿，这点还是比较给力的），2021-3-10状态变为Reviews Received，2021-3-22给出大修、意见给的也很专业、对文章提高有帮助（杂志社要求2021-6-20之前返回修改稿，时间给的比较充分），努力干了一个月，2021-4-30重新提交，technical check 4天后under review，2021-5-17状态变为了Reviews Received，目前本人祈祷不要拒稿中ing......个人觉得这本杂志还是比较靠谱的，个人经验，仅供参考，无意引战，谢绝反驳，也祝愿各位看官的paper投哪中哪，当然也包括我自己！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2acd90203, createdName=aipeter9194, createdTime=Mon May 17 07:31:28 CST 2021, time=2021-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2194070, encodeId=622221940e074, content=23年12月初peer review，现在显示The editors' decision can take several weeks as they may consult peer reviewers.有没有小伙伴知道是什么意思啊？我中途一直在关注网站明明显示的都是邀请审稿人，也没看有审稿人同意审稿。是系统不会显示吗？有没有必要写邮件催一下。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211209/8c790d426a7f41acb532cdb3a72c5ac7/68f2ff877eb74ef395af90eaacbc8c98.jpg, createdBy=04ed1994321, createdName=Dr.sugar, createdTime=Tue Mar 19 14:15:05 CST 2024, time=2024-03-19, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2211132, encodeId=109a2211132fb, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：特别无语，投稿9个月，中间小修，又等了5个月，最后一句话拒稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9b08717541, createdName=ms2000000985925584, createdTime=Sat Jun 22 12:40:50 CST 2024, time=2024-06-22, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2193258, encodeId=7038219325860, content=审稿速度:24.0 | 投稿命中率:25.0 经验分享：23-11-22投的，现在还在邀请编辑，写了几次催稿信，但都只是说还在邀请。着急的慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a838857884, createdName=ms5000000372122066, createdTime=Thu Mar 14 19:13:11 CST 2024, time=2024-03-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2186822, encodeId=01352186822ba, content=审稿速度:2.0 偏重的研究方向：非肿瘤 经验分享：2个月review，给了2周小修之后返回，审稿人不专业，发的孟德尔随机化完全不懂乱审一通，2个月返回之后拒掉了，全程4个月，有类似研究的慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b6f8797712, createdName=ms3000001167906308, createdTime=Sat Feb 10 18:23:39 CST 2024, time=2024-02-10, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2119112, encodeId=91a3211911291, content=朋友们，技术审查需要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f488130699, createdName=ms9000000792208563, createdTime=Sun Mar 12 19:41:24 CST 2023, time=2023-03-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2183750, encodeId=bb0a2183e5072, content=审稿速度:6.0 经验分享：马上4个月了，无语, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9b08717541, createdName=ms2000000985925584, createdTime=Wed Jan 24 20:44:15 CST 2024, time=2024-01-24, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2176028, encodeId=c65f21e60284f, content=偏重的研究方向：肿瘤分子流行病学 经验分享：2个月了，还是Editors invited ,还有希望不，有没有发过大佬的给分享一下投稿经验？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61ce6163316, createdName=ms8000001907184267, createdTime=Wed Dec 20 07:41:23 CST 2023, time=2023-12-20, status=1, ipAttribution=山东省)]

2024-02-10 ms3000001167906308 来自陕西省

审稿速度:2.0
偏重的研究方向：非肿瘤
经验分享：2个月review，给了2周小修之后返回，审稿人不专业，发的孟德尔随机化完全不懂乱审一通，2个月返回之后拒掉了，全程4个月，有类似研究的慎投

96 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1205377, encodeId=2e5112053e7da, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：生物信息分析 经验分享：从提交到接收四个月，中间修了两次，算是比较幸运的，遇到了好编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fc1b5547492, createdName=ms6000000247118819, createdTime=Wed Mar 23 21:55:57 CST 2022, time=2022-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2142457, encodeId=938f214245e63, content=还接受纯生信吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9048588526, createdName=ms9000001377282776, createdTime=Mon Jun 12 22:33:13 CST 2023, time=2023-06-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=966158, encodeId=e71b9661585a, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：心血管 经验分享：2020-12-25投稿，在编辑手里呆了几天后under review，2021-2月底邮件询问审稿状态（编辑很快就回复了还在审稿，这点还是比较给力的），2021-3-10状态变为Reviews Received，2021-3-22给出大修、意见给的也很专业、对文章提高有帮助（杂志社要求2021-6-20之前返回修改稿，时间给的比较充分），努力干了一个月，2021-4-30重新提交，technical check 4天后under review，2021-5-17状态变为了Reviews Received，目前本人祈祷不要拒稿中ing......个人觉得这本杂志还是比较靠谱的，个人经验，仅供参考，无意引战，谢绝反驳，也祝愿各位看官的paper投哪中哪，当然也包括我自己！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2acd90203, createdName=aipeter9194, createdTime=Mon May 17 07:31:28 CST 2021, time=2021-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2194070, encodeId=622221940e074, content=23年12月初peer review，现在显示The editors' decision can take several weeks as they may consult peer reviewers.有没有小伙伴知道是什么意思啊？我中途一直在关注网站明明显示的都是邀请审稿人，也没看有审稿人同意审稿。是系统不会显示吗？有没有必要写邮件催一下。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211209/8c790d426a7f41acb532cdb3a72c5ac7/68f2ff877eb74ef395af90eaacbc8c98.jpg, createdBy=04ed1994321, createdName=Dr.sugar, createdTime=Tue Mar 19 14:15:05 CST 2024, time=2024-03-19, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2211132, encodeId=109a2211132fb, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：特别无语，投稿9个月，中间小修，又等了5个月，最后一句话拒稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9b08717541, createdName=ms2000000985925584, createdTime=Sat Jun 22 12:40:50 CST 2024, time=2024-06-22, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2193258, encodeId=7038219325860, content=审稿速度:24.0 | 投稿命中率:25.0 经验分享：23-11-22投的，现在还在邀请编辑，写了几次催稿信，但都只是说还在邀请。着急的慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a838857884, createdName=ms5000000372122066, createdTime=Thu Mar 14 19:13:11 CST 2024, time=2024-03-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2186822, encodeId=01352186822ba, content=审稿速度:2.0 偏重的研究方向：非肿瘤 经验分享：2个月review，给了2周小修之后返回，审稿人不专业，发的孟德尔随机化完全不懂乱审一通，2个月返回之后拒掉了，全程4个月，有类似研究的慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b6f8797712, createdName=ms3000001167906308, createdTime=Sat Feb 10 18:23:39 CST 2024, time=2024-02-10, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2119112, encodeId=91a3211911291, content=朋友们，技术审查需要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f488130699, createdName=ms9000000792208563, createdTime=Sun Mar 12 19:41:24 CST 2023, time=2023-03-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2183750, encodeId=bb0a2183e5072, content=审稿速度:6.0 经验分享：马上4个月了，无语, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9b08717541, createdName=ms2000000985925584, createdTime=Wed Jan 24 20:44:15 CST 2024, time=2024-01-24, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2176028, encodeId=c65f21e60284f, content=偏重的研究方向：肿瘤分子流行病学 经验分享：2个月了，还是Editors invited ,还有希望不，有没有发过大佬的给分享一下投稿经验？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61ce6163316, createdName=ms8000001907184267, createdTime=Wed Dec 20 07:41:23 CST 2023, time=2023-12-20, status=1, ipAttribution=山东省)]

2023-03-12 ms9000000792208563 来自广东省

朋友们，技术审查需要多久呀

104 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=1205377, encodeId=2e5112053e7da, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：生物信息分析 经验分享：从提交到接收四个月，中间修了两次，算是比较幸运的，遇到了好编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fc1b5547492, createdName=ms6000000247118819, createdTime=Wed Mar 23 21:55:57 CST 2022, time=2022-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2142457, encodeId=938f214245e63, content=还接受纯生信吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9048588526, createdName=ms9000001377282776, createdTime=Mon Jun 12 22:33:13 CST 2023, time=2023-06-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=966158, encodeId=e71b9661585a, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：心血管 经验分享：2020-12-25投稿，在编辑手里呆了几天后under review，2021-2月底邮件询问审稿状态（编辑很快就回复了还在审稿，这点还是比较给力的），2021-3-10状态变为Reviews Received，2021-3-22给出大修、意见给的也很专业、对文章提高有帮助（杂志社要求2021-6-20之前返回修改稿，时间给的比较充分），努力干了一个月，2021-4-30重新提交，technical check 4天后under review，2021-5-17状态变为了Reviews Received，目前本人祈祷不要拒稿中ing......个人觉得这本杂志还是比较靠谱的，个人经验，仅供参考，无意引战，谢绝反驳，也祝愿各位看官的paper投哪中哪，当然也包括我自己！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2acd90203, createdName=aipeter9194, createdTime=Mon May 17 07:31:28 CST 2021, time=2021-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2194070, encodeId=622221940e074, content=23年12月初peer review，现在显示The editors' decision can take several weeks as they may consult peer reviewers.有没有小伙伴知道是什么意思啊？我中途一直在关注网站明明显示的都是邀请审稿人，也没看有审稿人同意审稿。是系统不会显示吗？有没有必要写邮件催一下。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211209/8c790d426a7f41acb532cdb3a72c5ac7/68f2ff877eb74ef395af90eaacbc8c98.jpg, createdBy=04ed1994321, createdName=Dr.sugar, createdTime=Tue Mar 19 14:15:05 CST 2024, time=2024-03-19, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2211132, encodeId=109a2211132fb, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：特别无语，投稿9个月，中间小修，又等了5个月，最后一句话拒稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9b08717541, createdName=ms2000000985925584, createdTime=Sat Jun 22 12:40:50 CST 2024, time=2024-06-22, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2193258, encodeId=7038219325860, content=审稿速度:24.0 | 投稿命中率:25.0 经验分享：23-11-22投的，现在还在邀请编辑，写了几次催稿信，但都只是说还在邀请。着急的慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a838857884, createdName=ms5000000372122066, createdTime=Thu Mar 14 19:13:11 CST 2024, time=2024-03-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2186822, encodeId=01352186822ba, content=审稿速度:2.0 偏重的研究方向：非肿瘤 经验分享：2个月review，给了2周小修之后返回，审稿人不专业，发的孟德尔随机化完全不懂乱审一通，2个月返回之后拒掉了，全程4个月，有类似研究的慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b6f8797712, createdName=ms3000001167906308, createdTime=Sat Feb 10 18:23:39 CST 2024, time=2024-02-10, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2119112, encodeId=91a3211911291, content=朋友们，技术审查需要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f488130699, createdName=ms9000000792208563, createdTime=Sun Mar 12 19:41:24 CST 2023, time=2023-03-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2183750, encodeId=bb0a2183e5072, content=审稿速度:6.0 经验分享：马上4个月了，无语, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9b08717541, createdName=ms2000000985925584, createdTime=Wed Jan 24 20:44:15 CST 2024, time=2024-01-24, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2176028, encodeId=c65f21e60284f, content=偏重的研究方向：肿瘤分子流行病学 经验分享：2个月了，还是Editors invited ,还有希望不，有没有发过大佬的给分享一下投稿经验？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61ce6163316, createdName=ms8000001907184267, createdTime=Wed Dec 20 07:41:23 CST 2023, time=2023-12-20, status=1, ipAttribution=山东省)]

2024-01-24 ms2000000985925584 来自新疆

审稿速度:6.0
经验分享：马上4个月了，无语

83 0

[GetPortalCommentsPageByObjectIdResponse(id=1205377, encodeId=2e5112053e7da, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：生物信息分析 经验分享：从提交到接收四个月，中间修了两次，算是比较幸运的，遇到了好编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fc1b5547492, createdName=ms6000000247118819, createdTime=Wed Mar 23 21:55:57 CST 2022, time=2022-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2142457, encodeId=938f214245e63, content=还接受纯生信吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9048588526, createdName=ms9000001377282776, createdTime=Mon Jun 12 22:33:13 CST 2023, time=2023-06-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=966158, encodeId=e71b9661585a, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：心血管 经验分享：2020-12-25投稿，在编辑手里呆了几天后under review，2021-2月底邮件询问审稿状态（编辑很快就回复了还在审稿，这点还是比较给力的），2021-3-10状态变为Reviews Received，2021-3-22给出大修、意见给的也很专业、对文章提高有帮助（杂志社要求2021-6-20之前返回修改稿，时间给的比较充分），努力干了一个月，2021-4-30重新提交，technical check 4天后under review，2021-5-17状态变为了Reviews Received，目前本人祈祷不要拒稿中ing......个人觉得这本杂志还是比较靠谱的，个人经验，仅供参考，无意引战，谢绝反驳，也祝愿各位看官的paper投哪中哪，当然也包括我自己！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2acd90203, createdName=aipeter9194, createdTime=Mon May 17 07:31:28 CST 2021, time=2021-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2194070, encodeId=622221940e074, content=23年12月初peer review，现在显示The editors' decision can take several weeks as they may consult peer reviewers.有没有小伙伴知道是什么意思啊？我中途一直在关注网站明明显示的都是邀请审稿人，也没看有审稿人同意审稿。是系统不会显示吗？有没有必要写邮件催一下。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211209/8c790d426a7f41acb532cdb3a72c5ac7/68f2ff877eb74ef395af90eaacbc8c98.jpg, createdBy=04ed1994321, createdName=Dr.sugar, createdTime=Tue Mar 19 14:15:05 CST 2024, time=2024-03-19, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2211132, encodeId=109a2211132fb, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：特别无语，投稿9个月，中间小修，又等了5个月，最后一句话拒稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9b08717541, createdName=ms2000000985925584, createdTime=Sat Jun 22 12:40:50 CST 2024, time=2024-06-22, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2193258, encodeId=7038219325860, content=审稿速度:24.0 | 投稿命中率:25.0 经验分享：23-11-22投的，现在还在邀请编辑，写了几次催稿信，但都只是说还在邀请。着急的慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8a838857884, createdName=ms5000000372122066, createdTime=Thu Mar 14 19:13:11 CST 2024, time=2024-03-14, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2186822, encodeId=01352186822ba, content=审稿速度:2.0 偏重的研究方向：非肿瘤 经验分享：2个月review，给了2周小修之后返回，审稿人不专业，发的孟德尔随机化完全不懂乱审一通，2个月返回之后拒掉了，全程4个月，有类似研究的慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b6f8797712, createdName=ms3000001167906308, createdTime=Sat Feb 10 18:23:39 CST 2024, time=2024-02-10, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2119112, encodeId=91a3211911291, content=朋友们，技术审查需要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f488130699, createdName=ms9000000792208563, createdTime=Sun Mar 12 19:41:24 CST 2023, time=2023-03-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2183750, encodeId=bb0a2183e5072, content=审稿速度:6.0 经验分享：马上4个月了，无语, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9b08717541, createdName=ms2000000985925584, createdTime=Wed Jan 24 20:44:15 CST 2024, time=2024-01-24, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2176028, encodeId=c65f21e60284f, content=偏重的研究方向：肿瘤分子流行病学 经验分享：2个月了，还是Editors invited ,还有希望不，有没有发过大佬的给分享一下投稿经验？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61ce6163316, createdName=ms8000001907184267, createdTime=Wed Dec 20 07:41:23 CST 2023, time=2023-12-20, status=1, ipAttribution=山东省)]

2023-12-20 ms8000001907184267 来自山东省

偏重的研究方向：肿瘤分子流行病学
经验分享：2个月了，还是Editors invited ,还有希望不，有没有发过大佬的给分享一下投稿经验？

97 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务